Prednisolon STADA® 5 mg Tabletten
Sponsors
Ultragenyx Pharmaceutical Inc.
Conditions
Glycogen Storage Disease Type Ia (GSDIa)Late-onset Ornithine transcarbamylase (OTC) deficiencyWilson disease
Phase 1
Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Adenoassociated Virus Serotype 8-mediated Gene Transfer of Glucose-6-phosphatase in Patients With Glycogen Storage Disease Type Ia.
CompletedCTIS2023-508750-25-00
Start: 2022-01-11End: 2025-12-22Target: 30Updated: 2026-01-19
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Adeno-associated Virus Serotype 8 (AAV8)-mediated Gene Transfer of Human Ornithine Transcarbamylase (OTC) in Patients with Late-onset OTC Deficiency
Active, not recruitingCTIS2024-514337-38-00
Start: 2023-01-24Target: 32Updated: 2025-11-25